Bausch Health
BHC
5,76 €
Share price
1.95%
Change (1 day)
-12.75%
Change (1 year)
Categories
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.
Bausch Health (BHC) - Total debt
Total debt on the balance sheet as of March 2025 : €18.23 Billion
According to Bausch Health 's latest financial reports the company's total debt is €18.23 Billion. A company’s total debt is the sum of all current and non-current debts.
Bausch Health - Total debt on balance sheet (from 1996 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2024-12-31 | €20.77 B | 2.57% |
| 2023-12-31 | €20.25 B | 4.61% |
| 2022-12-31 | €19.35 B | -3.22% |
| 2021-12-31 | €20.00 B | 2.84% |
| 2020-12-31 | €19.45 B | -15.85% |
| 2019-12-31 | €23.11 B | 8.8% |
| 2018-12-31 | €21.24 B | 0.19% |
| 2017-12-31 | €21.20 B | -25.26% |
| 2016-12-31 | €28.37 B | -0.25% |
| 2015-12-31 | €28.44 B | 127.09% |
| 2014-12-31 | €12.52 B | -0.46% |
| 2013-12-31 | €12.58 B | 50.98% |
| 2012-12-31 | €8.33 B | 62.76% |
| 2011-12-31 | €5.12 B | 84.54% |
| 2010-12-31 | €2.77 B | 913.57% |
| 2009-12-31 | €0.27 B | 500.91% |
| 2008-12-31 | €45.56 M | |
| 2006-12-31 | €0.31 B | -15.64% |
| 2005-12-31 | €0.36 B | 4.45% |
| 2004-12-31 | €0.35 B | -45.29% |
| 2003-12-31 | €0.64 B | -9.73% |
| 2002-12-31 | €0.71 B | 1267.8% |
| 2001-12-31 | €52.26 M | -93.33% |
| 2000-12-31 | €0.78 B | 473.86% |
| 1999-12-31 | €0.13 B | 27.78% |
| 1998-12-31 | €0.10 B | 2489.8% |
| 1997-12-31 | €4.12 M | -30% |
| 1996-12-31 | €5.89 M |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 Onconova Therapeutics ONTX | N/A | N/A | 🇺🇸 USA |
 OPKO Health
OPK | €0.41 B | -97.71% | 🇺🇸 USA |